ARR,OCX,MTN,GIFT Stock Price and Quote

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

Dollar change +0.33
Percentage change 1.78	%

Peers: AGNC NLY TWO CIM DX MFA NYMT ORC IVR AI

| Held by: IJR VTI IWM VB VBR KBWD VXF REM IWN SPSM

Index	RUT	P/E	7.99	EPS (ttm)	2.36	Insider Own	0.58%	Shs Outstand	55.76M	Perf Week	-2.73%
Market Cap	1.07B	Forward P/E	4.66	EPS next Y	4.05	Insider Trans	3.95%	Shs Float	55.44M	Perf Month	2.28%
Income	119.66M	PEG	-	EPS next Q	0.98	Inst Own	48.33%	Short Float	8.92%	Perf Quarter	-6.27%
Sales	1.01B	P/S	1.06	EPS this Y	-16.59%	Inst Trans	4.32%	Short Ratio	3.07	Perf Half Y	-3.43%
Book/sh	23.86	P/B	0.79	EPS next Y	4.33%	ROA	0.96%	Short Interest	4.94M	Perf Year	-0.74%
Cash/sh	3.49	P/C	5.40	EPS next 5Y	-11.36%	ROE	10.31%	52W Range	17.35 - 21.93	Perf YTD	-2.43%
Dividend Est.	2.88 (15.28%)	P/FCF	4.62	EPS past 5Y	33.80%	ROI	9.09%	52W High	-14.04%	Beta	1.48
Dividend TTM	2.88 (15.28%)	Quick Ratio	-	Sales past 5Y	-3498.82%	Gross Margin	96.77%	52W Low	8.65%	ATR (14)	0.38
Dividend Ex-Date	Dec 16, 2024	Current Ratio	-	EPS Y/Y TTM	187.25%	Oper. Margin	64.80%	RSI (14)	45.08	Volatility	2.87% 1.63%
Employees	22	Debt/Eq	7.74	Sales Y/Y TTM	3488.66%	Profit Margin	11.81%	Recom	3.00	Target Price	20.17
Option/Short	Yes / Yes	LT Debt/Eq	0.00	EPS Q/Q	130.97%	Payout	-	Rel Volume	4.55	Prev Close	18.52
Sales Surprise	4.16%	EPS Surprise	1.96%	Sales Q/Q	233.08%	Earnings	Oct 23 AMC	Avg Volume	1.61M	Price	18.85
SMA20	-0.98%	SMA50	-1.57%	SMA200	-3.54%	Trades		Volume	7,324,399	Change	1.78%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-06-24	Initiated	Janney	Neutral	$20
Dec-06-23	Initiated	UBS	Neutral	$18.50
Feb-22-22	Reiterated	B. Riley Securities	Neutral	$11 → $9.50
Jul-14-21	Initiated	B. Riley Securities	Neutral	$11.50
Feb-18-21	Downgrade	Ladenburg Thalmann	Buy → Neutral
May-26-20	Upgrade	Credit Suisse	Underperform → Neutral	$9 → $9.50
Oct-24-19	Upgrade	Ladenburg Thalmann	Neutral → Buy	$18
Mar-27-19	Initiated	Nomura	Neutral
Nov-09-16	Upgrade	Nomura	Reduce → Neutral
May-04-16	Downgrade	Ladenburg Thalmann	Buy → Neutral
May-03-16	Reiterated	Deutsche Bank	Hold	$24 → $21
Feb-24-16	Downgrade	Nomura	Neutral → Reduce
Feb-23-16	Reiterated	Deutsche Bank	Hold	$24.50 → $24
Feb-01-16	Downgrade	Barclays	Equal Weight → Underweight	$23 → $19
Nov-10-15	Reiterated	Barclays	Equal Weight	$25 → $23
Oct-13-15	Reiterated	Barclays	Equal Weight	$3.50 → $25
Dec-30-14	Downgrade	MLV & Co	Buy → Hold	$4.50 → $4
Oct-31-14	Downgrade	Compass Point	Buy → Neutral	$5 → $4.25
Mar-24-14	Downgrade	Compass Point	Buy → Neutral	$5 → $4.50
Sep-17-13	Initiated	MLV & Co	Hold	$5

Show Previous Ratings

Dec-12-24 08:44AM	Is the Options Market Predicting a Spike in ARMOUR (ARR) Stock? (Zacks)
Dec-02-24 08:00AM	10 REITs To Supercharge Your Portfolio With Up To 18.6% Yield (Benzinga)
Nov-27-24 04:15PM	ARMOUR Residential REIT, Inc. Announces December 2024 Dividend Rate Per Common Share (GlobeNewswire)
Nov-06-24 12:46PM	Here's How You Can Earn $100 In Passive Income By Investing In ARMOUR Residential Stock (Benzinga)
Oct-25-24 04:10AM	Q3 2024 ARMOUR Residential REIT Inc Earnings Call (Thomson Reuters StreetEvents)
03:14AM	Loading…
03:14AM	ARMOUR Residential REIT Inc (ARR) Q3 2024 Earnings Call Highlights: Strong Capital Raise and ... (GuruFocus.com)
Oct-23-24 06:15PM	Armour Residential REIT (ARR) Beats Q3 Earnings Estimates (Zacks)
05:09PM	Armour Residential REIT: Q3 Earnings Snapshot (Associated Press Finance)
04:15PM	ARMOUR Residential REIT, Inc. Announces Q3 Results and September 30, 2024 Financial Position (GlobeNewswire)
Oct-22-24 04:20PM	ARMOUR Residential REIT, Inc. Announces November 2024 Dividend Rate per Common Share (GlobeNewswire)
04:15PM	ARMOUR Residential REIT, Inc. Third Quarter 2024 Webcast Scheduled for October 24, 2024 (GlobeNewswire)
Oct-16-24 12:00PM	All You Need to Know About Armour Residential REIT (ARR) Rating Upgrade to Buy (Zacks)
Oct-01-24 04:15PM	ARMOUR Residential REIT, Inc. Confirms October 2024 Common Share and Series C Preferred Share Dividends (GlobeNewswire)
Sep-24-24 04:15PM	ARMOUR Residential REIT, Inc. Announces Guidance for October 2024 Dividend Rate per Common Share (GlobeNewswire)
Aug-29-24 04:15PM	ARMOUR Residential REIT, Inc. Announces September 2024 Dividend Rate Per Common Share (GlobeNewswire)
02:27AM	Loading…
Aug-23-24 02:27AM	ARMOUR Residential REIT, Inc. (ARR): A High-Yield REIT with Consistent Dividend Payments (Insider Monkey)
Aug-16-24 09:44PM	10 Highest Paying Monthly Dividend Stocks (Insider Monkey)
Aug-05-24 11:03AM	Implied Volatility Surging for ARMOUR Residential REIT (ARR) Stock Options (Zacks)
Jul-31-24 09:30AM	3 Dividend Stocks to Sell Before You Regret It (InvestorPlace)
Jul-24-24 09:53PM	ARR Stock Earnings: ARMOUR Residential REIT Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace)
06:05PM	Armour Residential REIT (ARR) Beats Q2 Earnings Estimates (Zacks)
05:03PM	Armour Residential REIT: Q2 Earnings Snapshot (Associated Press Finance)
04:15PM	ARMOUR Residential REIT, Inc. Announces Q2 Results and June 30, 2024 Financial Position (GlobeNewswire)
Jul-23-24 04:20PM	ARMOUR Residential REIT, Inc. Announces August 2024 Dividend Rate per Common Share (GlobeNewswire)
04:15PM	ARMOUR Residential REIT, Inc. Second Quarter 2024 Webcast Scheduled for July 25, 2024 (GlobeNewswire)
Jul-15-24 03:00PM	If You Like Passive Income REITs, You'll Love This One Paying A Dividend Over 14% (Benzinga)
Jul-01-24 04:15PM	ARMOUR Residential REIT, Inc. Confirms July 2024 Common Share and Series C Preferred Share Dividends (GlobeNewswire)
Jun-24-24 04:15PM	ARMOUR Residential REIT, Inc. Announces Guidance for July 2024 Dividend Rate per Common Share (GlobeNewswire)
Jun-11-24 08:14AM	Do Options Traders Know Something About Armour Residential (ARR) Stock We Don't? (Zacks)
May-30-24 04:15PM	ARMOUR Residential REIT, Inc. Announces June 2024 Dividend Rate Per Common Share (GlobeNewswire)
07:50AM	Loading…
May-13-24 07:50AM	5 Monthly Dividend Stocks with Over 5% Yield (Insider Monkey)
Apr-30-24 09:04AM	ARMOUR Residential REIT, Inc. (NYSE:ARR) Q1 2024 Earnings Call Transcript (Insider Monkey)
Apr-26-24 11:01PM	Q1 2024 ARMOUR Residential REIT Inc Earnings Call (Thomson Reuters StreetEvents)
04:15PM	High Risk, Low Reward For These REITs With Massive 13%+ Yields (Benzinga)
Apr-25-24 09:54PM	ARR Stock Earnings: ARMOUR Residential REIT Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
06:21PM	Armour Residential REIT: Q1 Earnings Snapshot (Associated Press Finance)
05:57PM	ARMOUR Residential REIT Inc. Reports Q1 Earnings: A Detailed Analysis (GuruFocus.com)
04:15PM	ARMOUR Residential REIT, Inc. Announces Q1 Results and March 31, 2024 Financial Position (GlobeNewswire)
Apr-24-24 04:20PM	ARMOUR Residential REIT, Inc. Announces May 2024 Dividend Rate Per Common Share (GlobeNewswire)
04:15PM	ARMOUR Residential REIT, Inc. First Quarter 2024 Webcast Scheduled for April 26, 2024 (GlobeNewswire)
Apr-16-24 03:06AM	15 Best Monthly Dividend Stocks To Buy Right Now (Insider Monkey)
Apr-08-24 02:45PM	Bearish Blades: 3 Falling Knives to Dodge in 2024 (InvestorPlace)
Apr-03-24 06:00PM	Armour Residential REIT (ARR) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
Apr-01-24 04:15PM	ARMOUR Residential REIT, Inc. Confirms April 2024 Common Share and Series C Preferred Share Dividends (GlobeNewswire)
Mar-28-24 06:00PM	Armour Residential REIT (ARR) Outperforms Broader Market: What You Need to Know (Zacks)
Mar-25-24 04:15PM	ARMOUR Residential REIT, Inc. Announces Guidance for April 2024 Dividend Rate Per Common Share (GlobeNewswire)
Mar-22-24 05:50PM	Armour Residential REIT (ARR) Dips More Than Broader Market: What You Should Know (Zacks)
Mar-21-24 06:00PM	Armour Residential REIT (ARR) Outpaces Stock Market Gains: What You Should Know (Zacks)
Mar-18-24 05:55PM	ARMOUR Residential REIT, Inc. Names Sergey Losyev and Desmond Macauley as Co-Chief Investment Officers (GlobeNewswire)
Mar-15-24 06:40PM	ARMOUR Residential REIT, Inc. Announces Retirement of Founder and Co-CEO Jeffrey J. Zimmer (GlobeNewswire)
05:50PM	Armour Residential REIT (ARR) Increases Despite Market Slip: Here's What You Need to Know (Zacks)
05:15PM	Armour Residential REIT: Q4 Earnings Snapshot (Associated Press Finance)
Mar-13-24 06:55PM	ARMOUR Residential REIT, Inc. Announces Chief Financial Officer Transition (GlobeNewswire) -5.60%
Mar-07-24 05:50PM	Here's Why Armour Residential REIT (ARR) Gained But Lagged the Market Today (Zacks)
Mar-01-24 05:50PM	Armour Residential REIT (ARR) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
04:21PM	ARMOUR Residential REIT, Inc. Announces Updated Estimated Book Value (GlobeNewswire)
04:20PM	ARMOUR Residential REIT, Inc. Files Form 12b-25 With the Securities and Exchange Commission (GlobeNewswire)
09:00AM	ARMOUR Residential REIT, Inc. (ARR) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Feb-24-24 02:26PM	11 Best Stocks That Pay Monthly Dividends in 2024 (Insider Monkey)
Feb-14-24 05:55PM	ARMOUR Residential REIT Inc. Reports Solid Q4 Earnings with Increased Book Value Per Share (GuruFocus.com) +5.58%
05:50PM	Armour Residential REIT (ARR) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
05:26PM	ARMOUR Residential REIT, Inc. Announces Preliminary Unaudited Q4 Results and December 31, 2023 Financial Position (GlobeNewswire)
06:30AM	ARMOUR Residential REIT, Inc. Announces March 2024 Dividend Rate Per Common Share (GlobeNewswire)
Feb-08-24 05:50PM	Armour Residential REIT (ARR) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)
09:00AM	ARMOUR Residential REIT, Inc. (ARR) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Feb-02-24 05:50PM	Armour Residential REIT (ARR) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
Feb-01-24 04:15PM	ARMOUR Residential REIT, Inc. Announces February 2024 Dividend Rate Per Common Share and Tax Allocation for 2023 Dividends (GlobeNewswire)
Jan-26-24 05:50PM	Armour Residential REIT (ARR) Flat As Market Sinks: What You Should Know (Zacks)
Jan-22-24 06:00PM	Armour Residential REIT (ARR) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
Jan-18-24 09:00AM	ARMOUR Residential REIT, Inc. (ARR) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Jan-16-24 06:00PM	Armour Residential REIT (ARR) Dips More Than Broader Market: What You Should Know (Zacks)
Jan-12-24 05:07AM	ARMOUR Residential REIT Inc's Dividend Analysis (GuruFocus.com)
Jan-09-24 06:00PM	Armour Residential REIT (ARR) Increases Despite Market Slip: Here's What You Need to Know (Zacks)
Jan-03-24 06:00PM	Why Armour Residential REIT (ARR) Dipped More Than Broader Market Today (Zacks)
Jan-02-24 06:30AM	ARMOUR Residential REIT, Inc. Confirms January 2024 Common Share and Series C Preferred Share Dividends (GlobeNewswire)
Dec-28-23 06:00PM	Armour Residential REIT (ARR) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
Dec-14-23 06:30AM	ARMOUR Residential REIT, Inc. Announces Guidance for January 2024 Dividend Rate Per Common Share and Updated Estimated Book Value (GlobeNewswire)
Dec-07-23 09:00AM	ARMOUR Residential REIT, Inc. (ARR) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Nov-23-23 09:00AM	Investors Heavily Search ARMOUR Residential REIT, Inc. (ARR): Here is What You Need to Know (Zacks)
Nov-16-23 04:44PM	The 7 Highest-Yielding Dividend Stocks in November (InvestorPlace)
Nov-02-23 09:00AM	Here is What to Know Beyond Why ARMOUR Residential REIT, Inc. (ARR) is a Trending Stock (Zacks)
Oct-29-23 11:23AM	ARMOUR Residential REIT, Inc. (NYSE:ARR) Q3 2023 Earnings Call Transcript (Insider Monkey)
Oct-25-23 08:15PM	Armour Residential REIT (ARR) Q3 Earnings and Revenues Lag Estimates (Zacks)
07:03PM	Armour Residential REIT: Q3 Earnings Snapshot (Associated Press Finance)
04:15PM	ARMOUR Residential REIT, Inc. Announces Q3 Results and September 30, 2023 Financial Position; Increased Stock Repurchase Authorization (GlobeNewswire)
12:01PM	What's in Store for ARMOUR Residential (ARR) in Q3 Earnings? (Zacks)
Oct-24-23 04:15PM	ARMOUR Residential REIT, Inc. Third Quarter 2023 Webcast Scheduled for October 26, 2023 (GlobeNewswire)
Oct-16-23 06:00PM	Armour Residential REIT (ARR) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
Oct-13-23 07:08AM	ARMOUR Residential REIT Inc's Dividend Analysis (GuruFocus.com)
Oct-10-23 06:00PM	Here's Why Armour Residential REIT (ARR) Gained But Lagged the Market Today (Zacks)
Oct-06-23 09:00AM	Is Trending Stock ARMOUR Residential REIT, Inc. (ARR) a Buy Now? (Zacks)
Oct-04-23 06:00PM	Armour Residential REIT (ARR) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
Oct-02-23 06:15AM	ARMOUR Residential REIT, Inc. Confirms Q4 2023 Common Share and Series C Preferred Share Dividends (GlobeNewswire)
06:05AM	ARMOUR Residential REIT, Inc. Announces Effectiveness of One-For-Five Reverse Stock Split (GlobeNewswire)
Sep-28-23 06:00PM	Armour Residential REIT (ARR) Stock Sinks As Market Gains: What You Should Know (Zacks)
Sep-22-23 06:00PM	Armour Residential REIT (ARR) Gains As Market Dips: What You Should Know (Zacks)
09:00AM	ARMOUR Residential REIT, Inc. (ARR) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Sep-19-23 06:20AM	Should You Invest in the Invesco KBW High Dividend Yield Financial ETF (KBWD)? (Zacks)
Sep-15-23 05:50PM	Armour Residential REIT (ARR) Gains As Market Dips: What You Should Know (Zacks)
Sep-14-23 06:00PM	Armour Residential REIT (ARR) Stock Sinks As Market Gains: What You Should Know (Zacks)

ARMOUR Residential REIT, Inc. operates as a real estate investment trust, which engages in the investment in business of investing in fixed rate, hybrid adjustable rate and adjustable rate residential mortgage backed securities. It also invests in residential mortgage backed securities issued or guaranteed by a United States government-sponsored entity such as the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation or guaranteed by the Government National Mortgage Administration. The company was founded on February 5, 2008 and is headquartered in Vero Beach, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Behar Z Jamie	Director	Nov 20 '24	Option Exercise	0.00	540	0	10,401	Nov 22 05:43 PM
HOLLIHAN JOHN P III	Director	Nov 20 '24	Option Exercise	0.00	540	0	12,413	Nov 22 05:42 PM
Downey Carolyn	Director	Nov 20 '24	Option Exercise	0.00	540	0	19,779	Nov 22 05:42 PM
Hain Robert C	Director	Nov 20 '24	Option Exercise	0.00	540	0	9,563	Nov 22 05:40 PM
PAPERIN STEWART J	Director	Nov 20 '24	Option Exercise	0.00	540	0	25,215	Nov 22 05:40 PM
BELL MARC H	Director	Nov 20 '24	Option Exercise	0.00	1,220	0	20,838	Nov 22 05:40 PM
STATON DANIEL C	Chairman of the Board	Nov 20 '24	Option Exercise	0.00	1,220	0	25,260	Nov 22 05:38 PM
Harper Gordon	CFO & Controller	Nov 20 '24	Option Exercise	0.00	2,100	0	15,986	Nov 22 05:37 PM
ULM SCOTT	CEO	Nov 20 '24	Option Exercise	0.00	4,380	0	66,442	Nov 22 05:37 PM
Hain Robert C	Director	Nov 07 '24	Buy	19.08	2,500	47,698	9,023	Nov 08 04:05 PM
STATON DANIEL C	Chairman of the Board	Oct 03 '24	Buy	19.86	10,000	198,570	24,040	Oct 04 05:40 PM
Harper Gordon	CFO & Controller	Aug 22 '24	Option Exercise	0.00	2,100	0	14,527	Aug 23 05:01 PM
STATON DANIEL C	Chairman of the Board	Aug 22 '24	Option Exercise	0.00	1,180	0	14,040	Aug 23 05:00 PM
BELL MARC H	Director	Aug 22 '24	Option Exercise	0.00	1,180	0	19,618	Aug 23 05:00 PM
PAPERIN STEWART J	Director	Aug 22 '24	Option Exercise	0.00	520	0	23,867	Aug 23 04:59 PM
ULM SCOTT	CEO	Aug 22 '24	Option Exercise	0.00	4,380	0	63,814	Aug 23 04:58 PM
Hain Robert C	Director	Aug 22 '24	Option Exercise	0.00	520	0	6,783	Aug 23 04:57 PM
HOLLIHAN JOHN P III	Director	Aug 22 '24	Option Exercise	0.00	520	0	12,081	Aug 23 04:56 PM
Downey Carolyn	Director	Aug 22 '24	Option Exercise	0.00	520	0	18,691	Aug 23 04:55 PM
Behar Z Jamie	Director	Aug 22 '24	Option Exercise	0.00	520	0	9,861	Aug 23 04:55 PM
Macauley Desmond	Co-Chief Investment Officer	May 30 '24	Buy	19.02	1,000	19,020	1,000	May 30 04:27 PM
STATON DANIEL C	Chairman of the Board	May 22 '24	Option Exercise	0.00	1,180	0	12,860	May 23 04:44 PM
Harper Gordon	CFO & Controller	May 22 '24	Option Exercise	0.00	2,100	0	13,061	May 23 04:43 PM
BELL MARC H	Director	May 22 '24	Option Exercise	0.00	1,180	0	18,438	May 23 04:42 PM
PAPERIN STEWART J	Director	May 22 '24	Option Exercise	0.00	520	0	22,496	May 23 04:40 PM
Hain Robert C	Director	May 22 '24	Option Exercise	0.00	520	0	6,523	May 23 04:39 PM
ULM SCOTT	CEO	May 22 '24	Option Exercise	0.00	4,380	0	61,186	May 23 04:37 PM
HOLLIHAN JOHN P III	Director	May 22 '24	Option Exercise	0.00	520	0	11,769	May 23 04:36 PM
Downey Carolyn	Director	May 22 '24	Option Exercise	0.00	520	0	17,580	May 23 04:34 PM
Behar Z Jamie	Director	May 22 '24	Option Exercise	0.00	520	0	9,341	May 23 04:33 PM
GRUBER MARK	CIO	Feb 22 '24	Option Exercise	0.00	1,660	0	23,588	Feb 26 04:18 PM
Harper Gordon	VP Finance and Controller	Feb 22 '24	Option Exercise	0.00	980	0	11,230	Feb 26 04:17 PM
MOUNTAIN JAMES R	Chief Financial Officer	Feb 22 '24	Option Exercise	0.00	1,860	0	21,362	Feb 26 04:16 PM
Behar Z Jamie	Director	Feb 22 '24	Option Exercise	0.00	520	0	8,821	Feb 26 04:14 PM
Downey Carolyn	Director	Feb 22 '24	Option Exercise	0.00	520	0	16,486	Feb 26 04:13 PM
HOLLIHAN JOHN P III	Director	Feb 22 '24	Option Exercise	0.00	520	0	11,457	Feb 26 04:12 PM
Hain Robert C	Director	Feb 22 '24	Option Exercise	0.00	520	0	6,263	Feb 26 04:10 PM
BELL MARC H	Director	Feb 22 '24	Option Exercise	0.00	1,180	0	17,258	Feb 26 04:06 PM
STATON DANIEL C	Chairman of the Board	Feb 22 '24	Option Exercise	0.00	1,180	0	11,680	Feb 26 04:04 PM
ULM SCOTT	Co-CEO	Feb 22 '24	Option Exercise	0.00	4,380	0	58,558	Feb 26 04:02 PM
Zimmer Jeffrey J	Co-CEO and President	Feb 22 '24	Option Exercise	0.00	4,380	0	53,587	Feb 26 04:01 PM
STATON DANIEL C	Chairman of the Board	Dec 29 '23	Sale	19.46	61,682	1,200,141	10,500	Dec 29 04:40 PM

Dollar change -0.02
Percentage change -0.90	%

OCX Oncocyte Corporation daily Stock Chart

Peers: EXAS CDNA GH FLGT ILMN MYGN BNTX RCKT CRSP TXG

| Held by: VTI VXF IWC DFAC

Index	-	P/E	-	EPS (ttm)	-4.43	Insider Own	20.28%	Shs Outstand	16.84M	Perf Week	-5.60%
Market Cap	36.54M	Forward P/E	-	EPS next Y	-1.67	Insider Trans	67.96%	Shs Float	13.42M	Perf Month	-20.36%
Income	-43.61M	PEG	-	EPS next Q	-0.43	Inst Own	51.24%	Short Float	1.64%	Perf Quarter	-30.48%
Sales	0.71M	P/S	51.46	EPS this Y	25.60%	Inst Trans	-	Short Ratio	3.20	Perf Half Y	-22.61%
Book/sh	0.73	P/B	3.02	EPS next Y	40.02%	ROA	-56.84%	Short Interest	0.22M	Perf Year	-23.43%
Cash/sh	0.20	P/C	10.87	EPS next 5Y	-	ROE	-165.32%	52W Range	1.98 - 3.82	Perf YTD	-12.40%
Dividend Est.	-	P/FCF	-	EPS past 5Y	14.72%	ROI	-351.16%	52W High	-42.67%	Beta	0.91
Dividend TTM	-	Quick Ratio	0.47	Sales past 5Y	16.25%	Gross Margin	-166.22%	52W Low	10.61%	ATR (14)	0.17
Dividend Ex-Date	-	Current Ratio	0.49	EPS Y/Y TTM	66.17%	Oper. Margin	-3227.36%	RSI (14)	29.79	Volatility	5.65% 8.09%
Employees	46	Debt/Eq	0.41	Sales Y/Y TTM	-	Profit Margin	-6150.92%	Recom	2.33	Target Price	4.12
Option/Short	No / Yes	LT Debt/Eq	0.28	EPS Q/Q	-21.47%	Payout	-	Rel Volume	1.14	Prev Close	2.21
Sales Surprise	-35.50%	EPS Surprise	7.99%	Sales Q/Q	-73.19%	Earnings	Nov 12 AMC	Avg Volume	68.61K	Price	2.19
SMA20	-8.44%	SMA50	-19.72%	SMA200	-24.12%	Trades		Volume	78,197	Change	-0.90%

Date	Action	Analyst	Rating Change	Price Target Change
May-24-22	Downgrade	Stephens	Overweight → Equal-Weight
Mar-14-22	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Jan-07-22	Initiated	Stephens	Overweight	$3.10
Jan-06-22	Resumed	Piper Sandler	Overweight	$3.10
Mar-17-21	Resumed	Needham	Buy	$8
Jan-07-21	Upgrade	The Benchmark Company	Speculative Buy → Buy	$6
Dec-16-20	Upgrade	Piper Sandler	Neutral → Overweight	$2 → $4
Nov-30-20	Initiated	BTIG Research	Buy	$5
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight	$5
Jul-30-20	Reiterated	The Benchmark Company	Speculative Buy	$7 → $6
Jul-01-20	Downgrade	Piper Sandler	Overweight → Neutral
Jun-30-20	Downgrade	Chardan Capital Markets	Buy → Neutral	$2
Jun-02-20	Initiated	Needham	Buy	$4
Feb-13-19	Initiated	Piper Jaffray	Overweight	$6
Jan-29-19	Upgrade	Janney	Neutral → Buy
Dec-19-18	Resumed	Lake Street	Buy

Show Previous Ratings

Dec-09-24 04:05PM	Oncocyte to Participate in J.P. Morgan Week and Host Investor Meetings (GlobeNewswire)
Dec-04-24 04:15PM	Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study (GlobeNewswire)
Dec-02-24 04:05PM	Oncocyte dd-cfDNA Assay Detects Kidney Transplant Rejection 11+ Months Ahead of Standard Protocols, New Study Affirms (GlobeNewswire)
Nov-13-24 02:21AM	OncoCyte Corp (OCX) Q3 2024 Earnings Call Highlights: Progress in Transplant Testing and ... (GuruFocus.com)
Nov-12-24 04:05PM	Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025 (GlobeNewswire)
04:45PM	Loading…
Nov-06-24 04:45PM	Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12 (GlobeNewswire)
Oct-16-24 04:15PM	Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles (GlobeNewswire)
Oct-08-24 08:30AM	Oncocyte's DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial (GlobeNewswire)
Oct-04-24 06:28AM	OncoCyte Secures Funding Through Private Share Sale (TipRanks)
Oct-02-24 06:41PM	Oncocyte Signs Leading Transplant Centers in US and Germany (GlobeNewswire)
06:35PM	Oncocyte Corporation Announces $10.2 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules (GlobeNewswire)
Aug-20-24 09:00AM	PRISM MarketView Features Oncocyte CFO Andrea S. James on Her Career and Leadership in Molecular Diagnostics Technology (GlobeNewswire)
Aug-12-24 04:10PM	Oncocyte's VitaGraft Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study (GlobeNewswire) -5.13%
Aug-08-24 04:05PM	Oncocyte Announces Successful GraftAssure Beta Launch and Q2 2024 Results (GlobeNewswire)
Aug-05-24 04:05PM	Oncocyte Announces August Investor Conferences Participation (GlobeNewswire) +6.27%
04:05PM	Loading…
Aug-01-24 04:05PM	Oncocyte to Announce Second Quarter 2024 Financial Results on August 8 (GlobeNewswire) -5.14%
Jul-11-24 08:00AM	MedTech Gurus Podcast Features Oncocyte CEO Josh Riggs in 'Take Advantage of the Moment' Episode (GlobeNewswire)
Jun-24-24 12:41PM	Oncocyte Bolsters Executive Team with Key CFO Appointment: PRISM MarketView Highlights Strategic Leadership Move (GlobeNewswire) -6.36%
Jun-17-24 04:05PM	Oncocyte Appoints Andrea James as Chief Financial Officer (GlobeNewswire)
Jun-05-24 07:00AM	OncoCyte's Innovative Approach: Potential in Precision Diagnostics (News Direct)
Jun-03-24 02:13PM	Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte's VitaGraft Study (GlobeNewswire)
May-30-24 04:47PM	Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine (GlobeNewswire)
May-15-24 08:55PM	OCX Stock Earnings: OncoCyte Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
04:05PM	Oncocyte Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-13-24 08:00AM	Oncocyte to Announce First Quarter 2024 Financial Results (GlobeNewswire)
May-07-24 09:19AM	PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics Marketplace (GlobeNewswire)
Apr-12-24 10:52AM	OCX Stock Earnings: OncoCyte Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace) -8.60%
06:00AM	Oncocyte Reports Full Year 2023 Financial Results (GlobeNewswire)
Apr-11-24 09:46PM	Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules (GlobeNewswire)
05:30PM	Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay (GlobeNewswire)
04:05PM	Loading…
Apr-09-24 04:05PM	Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Jan-16-24 08:00AM	Oncocyte to Present at the Sequire Investor Summit in Puerto Rico (GlobeNewswire)
Dec-06-23 08:00AM	Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays (GlobeNewswire)
Nov-09-23 08:27AM	OncoCyte Corp (OCX) Reports Q3 2023 Financial Results with Key Product Launches on the Horizon (GuruFocus.com) +29.71%
07:00AM	Oncocyte Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-03-23 08:30AM	Oncocyte to Announce Third Quarter 2023 Financial Results (GlobeNewswire) +8.09%
Sep-18-23 08:00AM	Oncocyte's VitaGraftTM Kidney Identifies Transplant Rejection 10 Months Earlier (ACCESSWIRE) +5.49%
Sep-06-23 08:00AM	Oncocyte to Participate in the H.C. Wainwright 25th Annual Global Investment Conference (ACCESSWIRE)
Aug-28-23 08:30AM	Oncocyte's VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage (ACCESSWIRE)
Aug-10-23 07:00AM	Oncocyte Reports Second Quarter 2023 Financial Results (ACCESSWIRE)
Aug-09-23 08:00AM	Oncocyte Regains Compliance With Nasdaq Listing Requirements (ACCESSWIRE)
Aug-08-23 08:30AM	Oncocyte to Participate in 8th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference (ACCESSWIRE) -5.29%
Aug-03-23 08:00AM	Oncocyte To Announce Second Quarter 2023 Financial Results (ACCESSWIRE)
Jul-25-23 09:08AM	VitaGraft Kidney Expands Utility in Recurrent Primary Disease Patients (GlobeNewswire)
Jul-24-23 01:35PM	Oncocyte Announces 1-For-20 Reverse Stock Split (GlobeNewswire) -9.57%
Jun-27-23 08:30AM	Oncocyte Begins Manufacturing Transplant Blood Test (GlobeNewswire)
Jun-01-23 04:15PM	Oncocyte Corporation to Present at the LD Micro Invitational XIII (Newsfile) +6.55%
May-11-23 08:00AM	Oncocyte Reports First Quarter 2023 Financial Results (GlobeNewswire)
Apr-27-23 04:59PM	Oncocyte To Announce First Quarter 2023 Financial Results (GlobeNewswire) +9.86%
Apr-18-23 08:45AM	Oncocyte Presents New Data at AACR (GlobeNewswire)
Apr-12-23 04:15PM	Oncocyte Announces Reduction in Force (GlobeNewswire) -5.08%
Apr-07-23 08:24AM	Oncocyte Announces Publication of DetermaIO Results from AtezoTRIBE Study in Metastatic Colorectal Cancer (GlobeNewswire)
Apr-03-23 08:00AM	Oncocyte Pricing of $13.86 Million Public Offering of Common Stock (GlobeNewswire) -10.41%
Mar-31-23 05:00PM	Oncocyte Reports Preliminary Fourth Quarter and Full Year 2022 Financial Results and Plans to File Form 12b-25 to Extend Filing Date of Its Form 10-K (GlobeNewswire) +26.57%
Mar-29-23 04:01PM	Oncocyte Announces Date Change for Fourth Quarter and Full Year 2022 Earnings Call (GlobeNewswire) +5.52% -8.50%
Mar-15-23 04:01PM	Oncocyte to Announce Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire) -20.00% +51.50%
Mar-02-23 09:00AM	Oncocyte Appoints Joshua Riggs as President and Chief Executive Officer (GlobeNewswire)
Feb-22-23 08:00AM	Oncocyte Completes Razor Genomics Transaction (GlobeNewswire)
Dec-16-22 08:19AM	Oncocyte cuts 40% of staff (MarketWatch) -21.95%
08:00AM	Oncocyte Announces Initiatives to Focus Corporate Strategy (GlobeNewswire)
Nov-30-22 06:05PM	Oncocyte Announces the Appointment of Louis E. Silverman as a Member of Its Board of Directors (GlobeNewswire)
06:00PM	Oncocyte Announces Executive Leadership Changes (GlobeNewswire)
Nov-10-22 04:30PM	Oncocyte Reports Third Quarter 2022 Financial Results (GlobeNewswire) -21.72%
Oct-27-22 04:01PM	Oncocyte to Announce Third Quarter 2022 Financial Results (GlobeNewswire) -13.50%
Oct-06-22 08:00AM	DetermaIO Clinical Test to be used in SWOG Cancer Research Network Biomarker Study for Breast Cancer (GlobeNewswire)
Sep-07-22 08:00AM	Oncocyte Announces Unanimous Recommendation from the Advisory Panel for Clinical Diagnostic Laboratory Tests on DetermaRx to CMS (GlobeNewswire)
Aug-31-22 04:01PM	Oncocyte to Participate at the Lake Street 6th Annual Best Ideas Growth Conference (GlobeNewswire)
Aug-30-22 04:27PM	Oncocyte Announces Five-Year VA Contract for DetermaRx (GlobeNewswire) -6.93%
Aug-24-22 08:00AM	Oncocyte Announces Publication of the Validation of DetermaIO in Predicting Immune Therapy Response in Metastatic Bladder Cancer (GlobeNewswire)
Aug-10-22 04:05PM	Oncocyte Reports Second Quarter 2022 Financial Results (GlobeNewswire) +10.57%
Aug-03-22 04:01PM	Oncocyte to Participate at Upcoming Investor Conferences (GlobeNewswire) +13.60%
Aug-01-22 11:33AM	The past year for OncoCyte (NASDAQ:OCX) investors has not been profitable (Simply Wall St.)
05:00AM	Oncocyte Announces the Appointment of John Peter Gutfreund as Independent Member of Its Board of Directors Effective July 28, 2022 (GlobeNewswire)
Jul-27-22 04:01PM	Oncocyte to Announce Second Quarter 2022 Financial Results (GlobeNewswire)
Jul-13-22 08:00AM	Oncocyte Announces Market Entry and Early Adopter Program for Transplant Rejection Monitoring Business (GlobeNewswire) +5.75%
Jul-06-22 08:00AM	Oncocyte Presents DetermaIO Data in Podium Presentation at ESMO World Congress on Gastrointestinal Cancer 2022 (GlobeNewswire)
Jun-22-22 08:00AM	Oncocyte Hosting Key Opinion Webinar on the Role of DetermaIO and the Tumor Microenvironment in Clinical Practice (GlobeNewswire)
Jun-15-22 07:15AM	How Much Of OncoCyte Corporation (NASDAQ:OCX) Do Insiders Own? (Simply Wall St.)
May-26-22 05:00PM	Oncocyte Presents DetermaIO Data at ASCO 2022 Supporting the Tests Potential to Expand the Clinical Use of Immunotherapy (GlobeNewswire)
May-11-22 04:05PM	Oncocyte Reports First Quarter 2022 Financial Results (GlobeNewswire)
May-05-22 08:00AM	Oncocyte Completes Validation of TheraSure Transplant Monitor Test (GlobeNewswire)
Apr-28-22 04:01PM	Oncocyte to Announce First Quarter 2022 Financial Results (GlobeNewswire)
Apr-27-22 04:30PM	Oncocyte to Present New Data at ASCO 2022 Underpinning Pan-Cancer Clinical Utility of DetermaIO (GlobeNewswire)
Apr-22-22 09:26AM	A number of insiders bought OncoCyte Corporation (NASDAQ:OCX) stock last year, which is great news for shareholders (Simply Wall St.)
Apr-13-22 10:01PM	Oncocyte Corporation Announces Pricing of Public Offering of Common Stock and Warrants (GlobeNewswire)
05:12PM	Oncocyte Corporation Announces Proposed Public Offering of Common Stock and Warrants (GlobeNewswire)
05:10PM	Oncocyte Corporation Announces Pricing of Registered Direct Offering of 11,765 Shares of Series A Convertible Preferred Stock (GlobeNewswire)
Apr-11-22 08:00AM	Oncocyte Presents Confirmatory Data for DetermaIO at the American Association for Cancer Research Annual Meeting 2022 (GlobeNewswire)
Mar-28-22 08:00AM	Oncocyte to Present New Data Confirming Association of IO Score with Response to Immunotherapy Treatment for Bladder Cancer at the American Association for Cancer Research Annual Meeting 2022 (GlobeNewswire)
Mar-10-22 04:05PM	Oncocyte Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update (GlobeNewswire) +7.69% -7.86%
Mar-01-22 04:05PM	Oncocyte to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday March 10 (GlobeNewswire)
Feb-21-22 07:26AM	Shareholders in OncoCyte (NASDAQ:OCX) have lost 78%, as stock drops 12% this past week (Simply Wall St.)
Feb-10-22 08:00AM	Oncocyte to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire)
Jan-18-22 04:05PM	Oncocyte Announces Development and Co-Marketing Agreement with Thermo Fisher Scientific to Expand Access to Precision Oncology (GlobeNewswire) +15.87% -24.20%
Jan-06-22 09:43AM	What Type Of Shareholders Make Up OncoCyte Corporation's (NASDAQ:OCX) Share Registry? (Simply Wall St.)
Jan-04-22 08:00AM	Oncocyte Announces Peer-Reviewed Publication in Cancers Showing Utility of DetermaCNI Blood-Only Monitoring Test to Detect Recurrence Following Surgery in Epithelial Ovarian Cancer (GlobeNewswire)
Dec-09-21 06:00PM	Spotlight Poster Presentation at San Antonio Breast Cancer Symposium SABCS 2021 Shows Oncocytes DetermaIO Clinical Test Predicts Response to Immunotherapy in Triple Negative Breast Cancer (GlobeNewswire) -9.81% -6.28%
Dec-08-21 08:00AM	Oncocyte and Burning Rock Complete Technology Transfer Part Two and Prepare for Scaled Distribution of DetermaRx in China (GlobeNewswire) +10.42%
Dec-06-21 08:00AM	Oncocyte Corporation Hosting Business Update Call (GlobeNewswire)
Dec-02-21 08:00AM	Oncocyte to Present New Data on DetermaIO Clinical Test for Immunotherapy Response in Triple Negative Breast Cancer at San Antonio Breast Cancer Symposium 2021 (GlobeNewswire)

OncoCyte Corp. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. The firm also offers pharmaceutical services like multi-analyte test development and clinical trial services. The company was founded in September 2009 and is headquartered in Alameda, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
James Andrea S.	Chief Financial Officer	Dec 05 '24	Buy	2.29	20,000	45,800	53,670	Dec 09 08:00 AM
James Andrea S.	Chief Financial Officer	Oct 02 '24	Buy	2.97	33,670	100,000	33,670	Oct 04 07:40 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Oct 02 '24	Buy	2.95	1,315,339	3,877,619	6,244,405	Oct 04 07:00 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 11 '24	Buy	2.92	2,420,000	7,057,688	4,929,066	Apr 15 07:21 PM
Riggs Josh	CEO and President	Apr 11 '24	Buy	2.95	3,390	10,000	3,505	Apr 15 06:04 AM
Arno Andrew	Director	Apr 11 '24	Buy	2.95	33,898	99,999	69,054	Apr 15 06:02 AM

Dollar change +2.59
Percentage change 1.43	%

Peers: PLNT EXPE MAR HLT BKNG FUN MLCO PENN CHH NCLH

| Held by: IJH VTI SCHD VB VXF VBK MDY IWP SPMD IJK

Index	-	P/E	30.60	EPS (ttm)	6.02	Insider Own	3.49%	Shs Outstand	37.44M	Perf Week	-3.20%
Market Cap	7.00B	Forward P/E	21.94	EPS next Y	8.40	Insider Trans	-0.88%	Shs Float	36.13M	Perf Month	4.27%
Income	233.08M	PEG	-	EPS next Q	6.34	Inst Own	100.12%	Short Float	5.40%	Perf Quarter	-1.17%
Sales	2.89B	P/S	2.42	EPS this Y	25.20%	Inst Trans	-1.50%	Short Ratio	3.35	Perf Half Y	1.50%
Book/sh	11.86	P/B	15.54	EPS next Y	10.56%	ROA	4.09%	Short Interest	1.95M	Perf Year	-16.73%
Cash/sh	11.02	P/C	16.73	EPS next 5Y	-10.60%	ROE	43.28%	52W Range	165.00 - 236.92	Perf YTD	-13.66%
Dividend Est.	8.99 (4.88%)	P/FCF	22.44	EPS past 5Y	-3.67%	ROI	6.88%	52W High	-22.20%	Beta	1.13
Dividend TTM	8.72 (4.73%)	Quick Ratio	0.50	Sales past 5Y	6.04%	Gross Margin	32.73%	52W Low	11.71%	ATR (14)	5.64
Dividend Ex-Date	Dec 26, 2024	Current Ratio	0.61	EPS Y/Y TTM	11.75%	Oper. Margin	18.81%	RSI (14)	49.60	Volatility	3.20% 3.22%
Employees	53000	Debt/Eq	6.83	Sales Y/Y TTM	0.64%	Profit Margin	8.07%	Recom	2.71	Target Price	202.00
Option/Short	Yes / Yes	LT Debt/Eq	6.63	EPS Q/Q	-0.17%	Payout	141.02%	Rel Volume	1.73	Prev Close	181.73
Sales Surprise	4.20%	EPS Surprise	7.84%	Sales Q/Q	0.66%	Earnings	Dec 09 AMC	Avg Volume	582.03K	Price	184.32
SMA20	-1.40%	SMA50	3.21%	SMA200	-2.02%	Trades		Volume	1,006,709	Change	1.43%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-14-24	Initiated	UBS	Neutral	$185
Jun-07-24	Downgrade	JP Morgan	Neutral → Underweight	$217 → $176
Mar-26-24	Initiated	Mizuho	Buy	$256
Mar-08-24	Downgrade	BofA Securities	Buy → Neutral	$285 → $250
Sep-27-23	Initiated	Morgan Stanley	Equal-Weight	$273
Sep-26-23	Reiterated	JP Morgan	Neutral	$231 → $280
Sep-07-23	Upgrade	Truist	Hold → Buy	$263 → $290
Sep-05-23	Upgrade	Stifel	Hold → Buy	$268
Jun-29-22	Initiated	Barclays	Underweight	$217
Sep-21-21	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$355
Mar-25-21	Upgrade	BofA Securities	Neutral → Buy	$350
Jan-29-21	Initiated	JP Morgan	Neutral	$290
Jan-27-21	Resumed	Stifel	Hold	$286
Dec-17-20	Downgrade	New Street	Buy → Neutral
Dec-16-20	Downgrade	Berenberg	Buy → Hold	$279
Dec-07-20	Downgrade	Truist	Buy → Hold
Dec-01-20	Downgrade	William Blair	Outperform → Mkt Perform
Nov-23-20	Downgrade	Janney	Buy → Neutral
Aug-31-20	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Jun-01-20	Downgrade	Deutsche Bank	Buy → Hold	$201

Show Previous Ratings

Dec-10-24 12:02PM	Vail Resorts Benefits From Higher Prices, Good Early Season Weather (Investopedia)
10:44AM	Q1 2025 Vail Resorts Inc Earnings Call (Thomson Reuters StreetEvents)
05:33AM	These Stocks Are Moving the Most Today: Nvidia, Oracle, C3.ai, Planet Labs, Yext, eBay, and More (Barrons.com)
02:00AM	Vail Resorts Inc (MTN) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
Dec-09-24 06:00PM	Compared to Estimates, Vail Resorts (MTN) Q1 Earnings: A Look at Key Metrics (Zacks)
05:15PM	Loading…
05:15PM	Vail Resorts (MTN) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:16PM	Vail Resorts (NYSE:MTN) Reports Upbeat Q3 (StockStory)
04:11PM	Vail Resorts: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Vail Resorts Reports Fiscal 2025 First Quarter and Season Pass Sales Results, and Announces 2025 Capital Plan (PR Newswire)
Dec-08-24 07:38AM	What To Expect From Vail Resortss (MTN) Q3 Earnings (StockStory)
Dec-06-24 09:15AM	Stay Ahead of the Game With Vail Resorts (MTN) Q1 Earnings: Wall Street's Insights on Key Metrics (Zacks)
Dec-05-24 07:29PM	Vail Resorts, Inc. (MTN): A Bull Case Theory (Insider Monkey)
Nov-20-24 11:45AM	Vail Resorts Named One of America's Most Admired Workplaces 2025 by Newsweek (PR Newswire)
Nov-18-24 12:04PM	Two Weeks Left: Epic Passes Available Through Dec. 2 Only, Including $133 CAD 1-Day Whistler Blackcomb Day Pass (PR Newswire)
12:02PM	Two Weeks Left: Epic Passes Available Through Dec. 2 Only, Including $123 1-Day Pass to Vail, Breck, Park City & Whistler Blackcomb (PR Newswire)
07:00AM	Loading…
07:00AM	Vail Resorts Announces Fiscal 2025 First Quarter Earnings Release Date (PR Newswire)
Nov-04-24 01:39PM	When Traveling, Now More Than Ever: Time. Is. Money. (The Wall Street Journal)
08:00AM	How Much More Would You Pay to Wait Less on Vacation? (The Wall Street Journal)
Oct-29-24 12:06PM	Vail Resorts doubles mental health benefits access (HR Dive)
Oct-22-24 02:59AM	Leisure Facilities Stocks Q2 In Review: AMC Entertainment (NYSE:AMC) Vs Peers (StockStory)
Oct-21-24 05:35AM	Q2 Earnings Highs And Lows: Xponential Fitness (NYSE:XPOF) Vs The Rest Of The Leisure Facilities Stocks (StockStory)
Oct-16-24 08:04AM	Bear of the Day: Vail Resorts (MTN) (Zacks)
Oct-15-24 03:55AM	Q2 Earnings Highlights: Vail Resorts (NYSE:MTN) Vs The Rest Of The Leisure Facilities Stocks (StockStory)
Oct-07-24 04:18AM	Unpacking Q2 Earnings: Topgolf Callaway (NYSE:MODG) In The Context Of Other Leisure Facilities Stocks (StockStory)
Oct-02-24 01:55PM	Investors Dig In on Meta Platforms, Vail Resorts, Costco Wholesale, and More (Motley Fool)
Oct-01-24 09:09PM	New Vail Mountain Base Village Planned in Partnership Between Town of Vail, Vail Resorts, and East West Partners (PR Newswire)
Sep-27-24 04:32PM	Vail Resorts Stock Falls After Earnings (Motley Fool)
01:01PM	Vail Resorts Reports Mixed Q4 Results, Announces $100 Million Transformation Plan (Benzinga)
12:45PM	Theres No Business Like Snow Business (The Wall Street Journal)
12:29PM	Why Vail Resorts (MTN) Shares Are Sliding Today (StockStory)
12:00PM	Loading…
12:00PM	Q4 2024 Vail Resorts Inc Earnings Call (Thomson Reuters StreetEvents)
10:56AM	Vail Resorts Cutting Jobs as Losses Mount (Investopedia)
05:01AM	Vail Resorts Inc (MTN) Q4 2024 Earnings Call Transcript Highlights: Mixed Performance Amid ... (GuruFocus.com)
04:12AM	Vail Resorts details two-year transformation strategy (Hotel Management Network)
Sep-26-24 06:00PM	Here's What Key Metrics Tell Us About Vail Resorts (MTN) Q4 Earnings (Zacks)
05:15PM	Vail Resorts (MTN) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:20PM	Vail Resorts: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:16PM	Vail Resorts (NYSE:MTN) Posts Q2 Sales In Line With Estimates (StockStory)
04:06PM	Vail Resorts Announces Two-Year Transformation Plan to Enable the Next Phase of Growth and Global Expansion (PR Newswire)
04:05PM	Vail Resorts Reports Fiscal 2024 Fourth Quarter and Full Year Results and Provides Fiscal 2025 Outlook (PR Newswire)
Sep-25-24 09:01AM	Vail Resorts Inc (MTN) Q4 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
03:01AM	Vail Resorts (MTN) Reports Earnings Tomorrow: What To Expect (StockStory)
Sep-23-24 09:15AM	Stay Ahead of the Game With Vail Resorts (MTN) Q4 Earnings: Wall Street's Insights on Key Metrics (Zacks)
Sep-19-24 10:00AM	Earnings Preview: Vail Resorts (MTN) Q4 Earnings Expected to Decline (Zacks)
Sep-14-24 05:37PM	Is Vail Resorts, Inc. (MTN) the Best Casino Stock that Pay Dividends? (Insider Monkey)
Sep-09-24 08:43PM	My 3 Favorite Stocks to Buy Right Now (Motley Fool)
Sep-05-24 05:35PM	Vail Resorts Announces Fiscal 2024 Year-End Earnings Release Date (PR Newswire)
Aug-14-24 09:00AM	Whistler Blackcomb Announces 2024/25 Winter Season Opening Date & September Epic Pass Deadline Details (PR Newswire)
09:00AM	Vail Resorts Announces 24/25 Winter Season Opening Dates and Epic Pass Labor Day Deadline Details (PR Newswire)
Aug-13-24 08:43AM	Disappointing Ski Season Impacted Vail Resorts (MTN) in Q2 (Insider Monkey)
Aug-08-24 02:15AM	Should You Consider Increasing Your Position in Vail Resorts (MTN)? (Insider Monkey)
Aug-03-24 10:00AM	A Once-in-a-Decade Opportunity: 1 Magnificent Dividend Stock Down 50% to Buy Now and Hold Forever (Motley Fool)
Jul-30-24 08:03PM	$10 billion fund manager cites three favorite stocks (TheStreet)
Jul-22-24 03:22AM	Leisure Facilities Stocks Q1 In Review: Six Flags (NYSE:SIX) Vs Peers (StockStory)
Jul-12-24 05:01PM	Steven Romick's Strategic Moves in Q2 2024 Highlighted by Major Stake in Vail Resorts Inc (GuruFocus.com)
Jun-25-24 08:42AM	Does Agilysys (AGYS) Have a Long Runway for Growth? (Insider Monkey)
Jun-24-24 12:00PM	The National Brotherhood of Snowsports Selects Keystone Resort for 2025 Annual Summit (PR Newswire)
Jun-13-24 12:58PM	Here's Why Investors Should Retain Vail Resorts (MTN) Stock (Zacks)
Jun-11-24 01:13PM	Vail Resorts, Inc. (NYSE:MTN) Downgraded by JPMorgan (Insider Monkey)
09:06AM	Analysts on Wall Street Lower Ratings for These 10 Stocks (Insider Monkey)
07:10AM	3 Stocks Set to Bounce on Interest Rate Cuts (InvestorPlace)
01:29AM	Insider Buying at Vail Resorts Inc (MTN): EVP & CFO Angela Korch Acquires Shares (GuruFocus.com)
Jun-07-24 01:33PM	Top Stock Movers Now: GameStop, Docusign, Vail Resorts, and More (Investopedia) -10.32%
01:22PM	Argan, Graham rise; Vail Resorts, Tilly's fall, Friday, 6/7/2024 (Associated Press Finance)
11:37AM	Why Vail Resorts (MTN) Shares Are Falling Today (StockStory)
10:19AM	Vail Resorts Stock Tumbles as Low Snowfall Impacts Q3 Results (Investopedia)
10:01AM	Stocks to Watch Friday: GameStop, Nvidia, DocuSign, AMC (The Wall Street Journal)
09:13AM	Vail Resorts (MTN) Q3 Earnings Miss Estimates, Stock Declines (Zacks)
09:04AM	These Stocks Are Moving the Most Today: GameStop, AMC, Mission Produce, DocuSign, and More (Barrons.com)
08:03AM	Vail Resorts, Inc. (NYSE:MTN) Q3 2024 Earnings Call Transcript (Insider Monkey)
Jun-06-24 08:53PM	MTN Stock Earnings: Vail Resorts Misses EPS, Misses Revenue for Q3 2024 (InvestorPlace)
06:00PM	Here's What Key Metrics Tell Us About Vail Resorts (MTN) Q3 Earnings (Zacks)
05:51PM	DocuSign stock down on lower-than-expected Q2 billings guidance (Yahoo Finance Video)
05:46PM	Vail Stock Drops as Earnings, Guidance Disappoint (Barrons.com)
05:15PM	Vail Resorts (MTN) Q3 Earnings and Revenues Lag Estimates (Zacks)
04:17PM	Vail Resorts: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:17PM	Vail Resorts (NYSE:MTN) Reports Sales Below Analyst Estimates In Q1 Earnings, Stock Drops (StockStory)
04:05PM	Vail Resorts Reports Fiscal 2024 Third Quarter Results, Provides Updated Fiscal 2024 Guidance, and Provides Early Season Pass Sales Results (PR Newswire)
12:15PM	Vail Earnings Are Coming. Heres What to Expect. (Barrons.com)
Jun-05-24 03:02AM	Vail Resorts Earnings: What To Look For From MTN (StockStory)
Jun-03-24 09:29AM	Vail Resorts (MTN) to Post Q3 Earnings: What's in the Cards? (Zacks)
09:15AM	Exploring Analyst Estimates for Vail Resorts (MTN) Q3 Earnings, Beyond Revenue and EPS (Zacks)
Jun-02-24 07:00AM	What To Expect in the Markets This Week (Investopedia)
06:18AM	The Hilliest Town in the US (Insider Monkey)
06:16AM	20 Hilliest Cities and Towns in the US (Insider Monkey)
May-15-24 09:00AM	Vail Resorts Announces Fiscal 2024 Third Quarter Earnings Release Date (PR Newswire)
May-06-24 02:30PM	Seven Reasons to Buy your Epic Pass before Prices Increase May 27 (PR Newswire)
02:15PM	Seven Reasons to Buy your Epic Pass before Prices Increase Memorial Day, May 27 (PR Newswire)
May-02-24 05:58AM	Vail Resorts Closes on Acquisition of Crans-Montana Mountain Resort in Switzerland, the Company's Second Ski Resort in Europe (PR Newswire)
Apr-25-24 01:56PM	Here's Why Baron Real Estate Fund Exited Vail Resorts (MTN) (Insider Monkey)
Apr-24-24 05:27PM	Vail Resorts Announces Pricing of Senior Notes Offering (PR Newswire)
01:11PM	Vail Resorts Plans $600 Million Senior Notes Offering (MT Newswires)
09:20AM	Vail Resorts Announces Commencement of Senior Notes Offering (PR Newswire)
Apr-22-24 08:41AM	Vail Resorts (MTN) Reports Ski Season Metrics, Skier Visits Fall (Zacks)
Apr-19-24 08:00AM	Vail Resorts Reports Certain Ski Season Metrics for the Season-to-Date Period Ended April 14, 2024 (PR Newswire)
Apr-18-24 03:43AM	Q4 Earnings Outperformers: Six Flags (NYSE:SIX) And The Rest Of The Leisure Facilities Stocks (StockStory)
Apr-10-24 11:30AM	Vail Resorts (MTN) Up 2.7% Since Last Earnings Report: Can It Continue? (Zacks)
11:03AM	Here's Why You Should Steer Clear of Vail Resorts (MTN) Now (Zacks)
Apr-09-24 05:07AM	Spotting Winners: Vail Resorts (NYSE:MTN) And Leisure Facilities Stocks In Q4 (StockStory)
Apr-05-24 05:45AM	Winners And Losers Of Q4: Bowlero (NYSE:BOWL) Vs The Rest Of The Leisure Facilities Stocks (StockStory)

Vail Resorts, Inc. is a holding company, which engages in the operation of mountain resorts. It operates through the following segments: Mountain, Lodging, and Real Estate. The Mountain segment covers the operation of mountain resorts or ski areas, and related activities. The Lodging segment includes ownership of hotels, RockResorts, NPS concessionaire properties, condominium management, Colorado resort ground transportation operations, and mountain resort golf operations. The Real Estate segment owns, develops, and sells real estate in and around its resort communities. The company was founded by Pete Seibert and Earl Eaton in March 1957 and is headquartered in Broomfield, CO.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Vaughn Peter A	Director	Dec 16 '24	Sale	192.01	1,000	192,005	7,573	Dec 18 04:27 PM
Vaughn Peter A	Director	Dec 16 '24	Proposed Sale	191.86	1,000	191,864		Dec 17 11:27 AM
Korch Angela A	EVP & Chief Financial Officer	Oct 03 '24	Buy	173.09	165	28,561	2,187	Oct 04 08:07 PM
KATZ ROBERT A	Exec. Chair of the Board	Oct 01 '24	Option Exercise	126.11	60,912	7,681,628	292,299	Oct 03 04:32 PM
KATZ ROBERT A	Exec. Chair of the Board	Oct 02 '24	Sale	175.98	9,296	1,635,914	245,961	Oct 03 04:32 PM
SORTE JOHN F	Director	Oct 02 '24	Sale	173.07	1,670	289,027	45,111	Oct 02 07:08 PM
ROBERT A KATZ	Officer	Oct 02 '24	Proposed Sale	175.98	9,296	1,635,909		Oct 02 04:27 PM
SORTE JOHN F	Director	Oct 02 '24	Proposed Sale	174.60	1,670	291,582		Oct 02 08:54 AM
Lynch Kirsten A.	CEO & Director	Sep 29 '24	Option Exercise	0.00	8,036	0	37,737	Oct 01 05:32 PM
KATZ ROBERT A	Exec. Chair of the Board	Sep 29 '24	Option Exercise	0.00	1,785	0	246,350	Oct 01 05:31 PM
Rock William	President, Mountain Division	Sep 29 '24	Option Exercise	0.00	1,287	0	7,496	Oct 01 05:30 PM
Korch Angela A	EVP & Chief Financial Officer	Sep 29 '24	Option Exercise	0.00	1,195	0	2,366	Oct 01 05:29 PM
DeCecco Julie A.	General Counsel	Sep 29 '24	Option Exercise	0.00	709	0	792	Oct 01 05:27 PM
Sullivan Gregory Jon	EVP, Retail & Hospitality	Sep 29 '24	Option Exercise	0.00	739	0	2,157	Oct 01 05:25 PM
Gronberg Nathan Mark	VP, Controller & CAO	Sep 29 '24	Option Exercise	0.00	490	0	1,209	Oct 01 05:23 PM
DECKER SUSAN L	Director	Sep 29 '24	Option Exercise	0.00	1,031	0	8,108	Oct 01 05:20 PM
Rawlinson Nadia Nicole	Director	Sep 29 '24	Option Exercise	0.00	1,031	0	4,361	Oct 01 05:17 PM
SORTE JOHN F	Director	Sep 29 '24	Option Exercise	0.00	1,031	0	46,781	Oct 01 05:16 PM
Vaughn Peter A	Director	Sep 29 '24	Option Exercise	0.00	1,031	0	8,573	Oct 01 05:15 PM
SEWELL D BRUCE	Director	Sep 29 '24	Option Exercise	0.00	1,031	0	20,874	Oct 01 05:14 PM
Romanow Michele	Director	Sep 29 '24	Option Exercise	0.00	1,031	0	7,054	Oct 01 05:08 PM
REDMOND JOHN	Director	Sep 29 '24	Option Exercise	0.00	1,031	0	22,573	Oct 01 05:06 PM
SCHNEIDER HILARY	Director	Sep 29 '24	Option Exercise	0.00	1,031	0	15,830	Oct 01 05:04 PM
Gronberg Nathan Mark	VP, Controller & CAO	Sep 24 '24	Option Exercise	0.00	123	0	833	Sep 26 07:25 PM
DeCecco Julie A.	General Counsel	Sep 24 '24	Option Exercise	0.00	245	0	245	Sep 26 07:23 PM
Sullivan Gregory Jon	EVP, Retail & Hospitality	Sep 24 '24	Option Exercise	0.00	184	0	1,578	Sep 26 07:22 PM
Rock William	President, Mountain Division	Sep 24 '24	Option Exercise	0.00	246	0	6,409	Sep 26 07:20 PM
KATZ ROBERT A	Exec. Chair of the Board	Sep 24 '24	Option Exercise	0.00	491	0	244,985	Sep 26 06:54 PM
Lynch Kirsten A.	CEO & Director	Sep 24 '24	Option Exercise	0.00	2,209	0	32,263	Sep 26 06:52 PM
Korch Angela A	EVP & Chief Financial Officer	Jun 10 '24	Buy	176.20	575	101,315	1,171	Jun 10 06:21 PM
Vaughn Peter A	Director	Mar 13 '24	Sale	222.77	1,000	222,770	7,592	Mar 15 05:39 PM
Korch Angela A	EVP & Chief Financial Officer	Feb 01 '24	Option Exercise	0.00	880	0	717	Feb 05 05:26 PM

Dollar change +0.08
Percentage change 7.46	%

Peers: MCD UBER DASH YUM CMG QSR DPZ LYFT WEN EAT

Index	-	P/E	-	EPS (ttm)	-0.70	Insider Own	45.01%	Shs Outstand	26.13M	Perf Week	-25.00%
Market Cap	30.38M	Forward P/E	-	EPS next Y	-	Insider Trans	0.36%	Shs Float	14.39M	Perf Month	-36.09%
Income	-17.68M	PEG	-	EPS next Q	-	Inst Own	11.55%	Short Float	0.19%	Perf Quarter	-62.89%
Sales	149.79M	P/S	0.20	EPS this Y	-	Inst Trans	-	Short Ratio	0.66	Perf Half Y	-73.91%
Book/sh	0.85	P/B	1.27	EPS next Y	-	ROA	-86.87%	Short Interest	0.03M	Perf Year	-70.81%
Cash/sh	0.11	P/C	9.83	EPS next 5Y	-	ROE	-158.33%	52W Range	0.50 - 4.65	Perf YTD	-73.00%
Dividend Est.	-	P/FCF	-	EPS past 5Y	22.48%	ROI	-71.44%	52W High	-76.77%	Beta	-0.72
Dividend TTM	-	Quick Ratio	0.40	Sales past 5Y	546.87%	Gross Margin	9.36%	52W Low	116.00%	ATR (14)	0.19
Dividend Ex-Date	-	Current Ratio	0.80	EPS Y/Y TTM	-229.02%	Oper. Margin	-12.48%	RSI (14)	36.37	Volatility	13.97% 12.35%
Employees	64	Debt/Eq	0.46	Sales Y/Y TTM	4647.78%	Profit Margin	-11.81%	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	0.12	EPS Q/Q	-1103.08%	Payout	-	Rel Volume	0.82	Prev Close	1.00
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	3951.35%	Earnings	-	Avg Volume	41.19K	Price	1.08
SMA20	-21.89%	SMA50	-27.64%	SMA200	-66.04%	Trades		Volume	33,763	Change	7.46%

Dec-20-24 10:15PM	Giftify, Inc. Announces Registered Direct Offering - CORRECTED (GlobeNewswire) +7.46%
04:00PM	Giftify, Inc. Announces $5.0 Million Registered Direct Offering (GlobeNewswire)
08:00AM	Giftify, Inc.'s CardCash Featured on ABC's Good Morning America (GlobeNewswire)
Dec-17-24 08:00AM	Giftify's CardCash Partners with Susan G. Komen to Transform Unused Gift Cards into Donations for Breast Cancer Research (GlobeNewswire) -6.11%
Dec-03-24 08:30AM	Giftify, Inc. to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference (GlobeNewswire) +5.06%
08:00AM	Loading…
Nov-25-24 08:00AM	Giftify, Inc. to Participate in The Noble Capital Markets' 20th Annual Emerging Growth Equity Conference (GlobeNewswire)
Nov-13-24 08:00AM	Giftify, Inc. Reports Third Quarter 2024 Financial Results, Reports Revenue Growth of 14.9% to $23.2 Million (GlobeNewswire) -5.33%
Oct-30-24 07:00AM	Presenting on the Emerging Growth Conference 76 Day 2 on October 31 Register Now (GlobeNewswire) -10.40%
Oct-29-24 07:00AM	Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now (GlobeNewswire)
Oct-28-24 08:30AM	Giftify, Inc. to Present on the Emerging Growth Conference on Wednesday, October 30, 2024 at 12:00pm EDT (GlobeNewswire)
Oct-25-24 10:30AM	RDE, Inc. Announces Rebranding with Name Change to Giftify, Inc. (GlobeNewswire)
Oct-15-24 02:00PM	The MicroCap Rodeo Fall Conference to Host Executive Teams of 19 Companies on October 16th in NYC (ACCESSWIRE)
08:35AM	RETRANSMISSION: RDE, Inc. to Present at the MicroCap Rodeo Fall Conference (ACCESSWIRE)
Oct-08-24 08:30AM	RDE, Inc. CFO Steve Handy Purchased 25,620 Shares in the Open Market (GlobeNewswire) -18.18%
Sep-12-24 08:30AM	RDE, Inc.'s CardCash.com Achieves Key Performance Milestones for its Merchants Utilizing its B2B Platform (GlobeNewswire)
08:30AM	Loading…
Sep-03-24 08:30AM	RDE, Inc. Announces NASDAQ Ticker Symbol Change to GIFT (GlobeNewswire) +8.70%
Aug-26-24 08:30AM	RDE, Inc. Appoints Steve Handy as Chief Financial Officer (GlobeNewswire) +5.48%
Aug-15-24 08:30AM	RDE, Inc. Reports $20.0 Million Revenue, Highlighted by 25% Increase in Gross Profit for the Second Quarter Ended June 30, 2024 (GlobeNewswire)
Aug-06-24 08:30AM	RDE, Inc. to Begin Trading on Nasdaq Capital Market on Wednesday, August 7th (GlobeNewswire)
May-16-24 08:30AM	RDE, Inc. Reports $21.5 Million Revenue, Highlighted by 12% Increase in Gross Profit for the First Quarter Ended March 31, 2024 (GlobeNewswire)

Giftify, Inc. engages in the ownership and operation of its subsidiary, Restaurant.com. It operates through the following divisions: Business to Customer (B2C), Business to Business (B2B), and other business. The company was founded in 1997 and is headquartered in Schaumburg, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Wellisch Balazs	CTO	Oct 10 '24	Buy	1.45	35,000	50,750	1,040,217	Oct 23 02:23 PM
Wellisch Balazs	CTO	Sep 09 '24	Buy	2.95	1,000	2,950	1,005,217	Oct 23 02:23 PM
Thakker Ketan	CEO	Oct 18 '24	Buy	1.49	10,000	14,900	2,694,208	Oct 22 06:02 AM

ARR

ARMOUR Residential REIT Inc

OCX

Oncocyte Corporation

MTN

Vail Resorts Inc

GIFT

Giftify Inc

Upgrade your FINVIZ experience